$AVK

Advent Convertible and Income Fund Cash Flow – NYSE:AVK

This article provides financial data for Advent Convertible and Income Fund (NYSE: AVK), focusing on its cash flow activities. For H2 2025, the free cash flow was $3.95 million USD, with the full-year 2025 free cash flow and operating cash flow both recorded at $9.85 million USD. The data details operating, investing, and financing activities, but specific year-over-year growth figures for these categories are not available in the provided table.

Original reporting
Published Mar 1, 2026, 12:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Mar 1, 2026, 1:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Advent Convertible and Income Fund Cash Flow – NYSE:AVK — source image
Decision brief

The 30-second read

$AVKNeutralLow
01

Why it matters

The cash flow figures alone do not suggest immediate trading opportunities but provide insight into the fund's financial stability.

02

Market read

Limited market impact based on current cash flow data; more relevant when combined with market price and broader financial metrics.

03

What to watch

Market sentiment, current stock price, and broader economic indicators are not considered here but could significantly influence trading decisions.

Relevance 6/10Timing: long-term

Background

Advent Convertible and Income Fund (NYSE: AVK) reported cash flows for H2 2025 and full-year 2025, indicating stable liquidity.

Company-level read

Ticker impact

$AVKNeutralMedium confidence
Context

Financial cash flow data for Advent Convertible and Income Fund (NYSE: AVK) as of March 1, 2026, with focus on H2 2025 free cash flow and full-year figures. Limited impact on trading decisions due to lack of current price and growth data.

Expected impact

Minimal short-term price movement expected based on cash flow data alone.

Evidence & confidence

Cash flow figures are stable but lack comparative growth data and current market context, limiting predictive power.

Market effects

The data suggests stability in the financial sector, with no immediate sector-wide disruptions indicated.

Limited regional impact expected given the company's US focus and stable cash flows.

Negligible global relevance based on cash flow data alone.

Counterpoint

While cash flow stability suggests financial health, some investors might interpret the lack of growth as a sign to avoid the stock.

Key entities

  • Advent Convertible and Income Fund

    A closed-end fund focusing on convertible securities and income-generating assets.

Related articles

$METAMedAI 9/10

Inside the Plot to Cover Europe with Gas-Powered AI Data Centres

DeSmog reports that gas turbine makers and sponsors at Brussels’ Datacloud Energy Europe said the UK and EU may allow natural-gas power for AI data centres, citing U.S. momentum. Companies including Mitsubishi Power Aero, Langley Holdings and MWM (Caterpillar) described projects in Europe/UK (up to 100 MW each). The article cites Cleanview estimating at least 23 GW of gas turbines planned in the U.S., and warns EU/UK emissions targets could be at risk.

$TRXBMed

JPMorgan initiates TRex Bio stock coverage with overweight rating

JPMorgan initiated coverage on TRex Bio (NASDAQ:TRXB) with an overweight rating and $20 price target, citing its unique approach to immune balance. The stock trades near its 52-week low at $13.64. TRex Bio's pipeline includes TRB-061 for atopic dermatitis and alopecia areata, with Phase 1b data upcoming. The company has a strong balance sheet and partnerships with Johnson & Johnson and Eli Lilly. Stifel also initiated coverage with a buy rating and $39 target.

$ONMed

Wells Fargo cuts ON Semiconductor stock price target on valuation

Wells Fargo reduced its price target for ON Semiconductor (NASDAQ:ON) to $90 from $100, citing mixed Q3 2026 results and market multiple compression. The stock is down 48% from its 52-week high. Despite this, Wells Fargo raised its revenue and earnings estimates for 2026-2028, expecting revenue of $6.64B and EPS of $3.30 for 2026. ON Semiconductor's Q3 2026 earnings beat expectations, but automotive revenue outlook was softer.

$PIPRMed

BofA cuts Piper Sandler stock price target on weak Q4 outlook

BofA Securities reduced Piper Sandler's (PIPR) price target to $69 from $75, maintaining an Underperform rating. Q3 earnings per share missed estimates at $0.87, with revenue meeting forecasts. BofA cited a weak Q4 outlook, projecting a 14% YoY revenue decline and lowering its Q4 EPS estimate to $1.16. PIPR stock is down 19% YTD, trading at $67.42.